Skip to main content
Terug
Watch Compare

PURE BIOSCIENCE, INC.

Datakwaliteit: 100%
PURE
OTC Manufacturing Chemicals
€ 0,08
▼ € 0,01 (-11,76%)
Marktkapitalisatie: 9,51 M
Prijs
€ 0,09
Marktkapitalisatie
9,51 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -12,20% annually over 5 years
Negative free cash flow of -1,82 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24,63%

Groei

Revenue Growth (5Y)
-12,20%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)12,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-89,97%
Op. Margin-82,51%

Veiligheid

Debt / Equity
N/A
Current Ratio0,25
Interest Coverage-5,74

Waardering

PE (TTM)
-4,40
Onder sectorgemiddelde (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -4,4 -1,5
P/B — 1,6
ROE % — -53,3
Net Margin % -90,0 -41,5
Rev Growth 5Y % -12,2 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q22018 -€ 0,02 -€ 0,02 0,0%
Q12018 -€ 0,02 -€ 0,03 -50,0%
Q42017 -€ 0,02 -€ 0,04 -100,0%
Q32017 -€ 0,03 -€ 0,02 +23,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12,43% Revenue Growth (3Y) 8,39%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -12,20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,40 M Net Income (TTM) -2,16 M
ROE N/A ROA -218,95%
Gross Margin 59,91% Operating Margin -82,51%
Net Margin -89,97% Free Cash Flow (TTM) -1,82 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,25
Interest Coverage -5,74 Asset Turnover 2,43
Working Capital -2,28 M Tangible Book Value -6,27 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,40 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3,96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19,18%
Market Cap 9,51 M Enterprise Value 9,31 M
Per Share
EPS (Diluted TTM) -0,02 Revenue / Share 0,02
FCF / Share -0,02 OCF / Share -0,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 84,41%
SBC-Adj. FCF -2,01 M Growth Momentum 24,63

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,20 M 1,96 M 1,87 M 1,81 M 3,70 M
Net Income -2,40 M -3,35 M -3,96 M -3,49 M -2,32 M
EPS (Diluted) -0,02 -0,03 -0,04 — -0,03
Gross Profit 1,30 M 1,15 M 971.000,0 1,00 M 2,08 M
Operating Income -2,27 M -3,19 M -3,94 M -3,72 M -2,31 M
EBITDA — — — — —
R&D Expenses 316.000,0 302.000,0 297.000,0 319.000,0 339.000,0
SG&A Expenses 3,26 M 3,98 M 4,30 M 4,11 M 4,05 M
D&A 2.000,0 148.000,0 117.000,0 213.000,0 172.000,0
Interest Expense 287.000,0 155.000,0 14.000,0 6.000,0 4.000,0
Income Tax 0,0 0,0 1.650,0 1.650,0 1.650,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,06 M 818.000,0 1,83 M 4,48 M 4,30 M
Total Liabilities 6,17 M 3,68 M 1,55 M 575.000,0 970.000,0
Shareholders' Equity -5,12 M -2,86 M 272.000,0 3,91 M 3,33 M
Total Debt — — — — —
Cash & Equivalents 334.000,0 349.000,0 1,10 M 3,39 M 2,39 M
Current Assets 1,05 M 805.000,0 1,60 M 3,86 M 3,20 M
Current Liabilities 938.000,0 733.000,0 532.000,0 575.000,0 970.000,0